sulotroban has been researched along with thromboxanes in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 15 (65.22) | 18.7374 |
| 1990's | 8 (34.78) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andersson, KE; Forman, A; Skajaa, K; Svane, D | 1 |
| Karasawa, A; Kubo, K; Shirakura, S | 1 |
| Bhakdi, S; Eberspächer, B; Grimminger, F; Holland, IB; Hugo, F; Obernitz, R; Seeger, W; Suttorn, N; Thomas, M; Walmrath, D | 1 |
| Bass, TA; Bove, AA; Cowley, M; Goldberg, S; Macdonald, RG; Margolis, JR; Savage, MP; Taussig, AS; Vetrovec, G; Whitworth, HB | 1 |
| Aksoy, MO; Harakal, C; Smith, JB; Stewart, GJ; Zerweck, CR | 1 |
| Battistini, B; Filep, JG; Sirois, P | 1 |
| Battistini, B; Filep, J; Sirois, P | 1 |
| Müller, B; Stürzebecher, S; Witt, W | 1 |
| McGiff, JC; Nasjletti, A; Quilley, J | 1 |
| Arnout, J; Deckmyn, H; Gresele, P; Nenci, GG; Vermylen, J | 1 |
| Darius, H; Lefer, AM | 1 |
| Hofmann, U; Leytin, VL; Misselwitz, F; Repin, VS | 1 |
| Ellendorf, B; Nerlich, M; Sturm, J; Sutter, G; Wisner, D | 1 |
| Hiller, E; Höfling, B; Riess, H; von Arnim, T | 1 |
| Parratt, JR; Wainwright, CL | 1 |
| Ceuppens, JL; Deckmyn, H; Vermylen, J; Vertessen, S | 1 |
| Patscheke, H; Stegmeier, K | 2 |
| Mest, HJ; Riedel, A; Schneider, S | 1 |
| McDonald, J; Smith, EF | 1 |
| Müller-Beckmann, B; Neugebauer, G; Patscheke, H; Sponer, G; Staiger, C; Stegmeier, K | 1 |
| Müller-Beckmann, B; Patscheke, H; Pill, J; Schmidt, FH; Stegmeier, K; Witte, EC; Wolff, HP | 1 |
| Uhlig, S; von Bethmann, A | 1 |
2 trial(s) available for sulotroban and thromboxanes
| Article | Year |
|---|---|
Multi-Hospital Eastern Atlantic Restenosis Trial. II: A placebo-controlled trial of thromboxane blockade in the prevention of restenosis following coronary angioplasty.
Topics: Angioplasty, Balloon, Coronary; Aspirin; Coronary Angiography; Coronary Disease; Double-Blind Method; Follow-Up Studies; Humans; Mid-Atlantic Region; Placebos; Platelet Aggregation Inhibitors; Prospective Studies; Receptors, Prostaglandin; Receptors, Thromboxane; Recurrence; Sulfonamides; Thromboxanes | 1991 |
Thromboxane receptor blockade versus cyclooxigenase inhibition: antiplatelet effects in patients.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Angioplasty, Balloon; Arteriosclerosis; Aspirin; Bleeding Time; Blood Platelets; Clinical Trials as Topic; Collagen; Cyclooxygenase Inhibitors; Female; Fibrinolytic Agents; Humans; Male; Middle Aged; Platelet Aggregation; Prostaglandin Endoperoxides, Synthetic; Receptors, Cell Surface; Receptors, Prostaglandin; Receptors, Thromboxane; Sulfonamides; Thromboxane B2; Thromboxanes | 1986 |
21 other study(ies) available for sulotroban and thromboxanes
| Article | Year |
|---|---|
Effects of the thromboxane-receptor antagonists AH 23848 and BM 13.177 on human uteroplacental arteries.
Topics: Adult; Arteries; Biphenyl Compounds; Dinoprost; Dinoprostone; Dose-Response Relationship, Drug; Female; Humans; In Vitro Techniques; Muscle Contraction; Placenta; Pregnancy; Prostaglandin Endoperoxides, Synthetic; Receptors, Prostaglandin; Receptors, Thromboxane; Sulfonamides; Thromboxanes; Uterus; Vasoconstriction; Vasopressins | 1992 |
Protective effects of the novel thromboxane A2 receptor antagonist sodium (E)-11-[2-(5,6-dimethyl-1-benzimidazolyl)-ethylidene]-6,11- dihydrodibenz[b,e]oxepine-2-carboxylate monohydrate against 9,11-dideoxy- 9 alpha, 11 alpha-epoxymethano-prostaglandin F2
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Aspirin; Benzimidazoles; Benzoxepins; Blood Pressure; Death, Sudden; Dose-Response Relationship, Drug; Guinea Pigs; Male; Phenylacetates; Platelet Aggregation Inhibitors; Platelet Count; Prostaglandin Endoperoxides, Synthetic; Rats; Rats, Inbred Strains; Sulfonamides; Thromboxane A2; Thromboxanes; Ticlopidine | 1991 |
Lung vascular injury after administration of viable hemolysin-forming Escherichia coli in isolated rabbit lungs.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Aspirin; Blood Pressure; Capillary Permeability; Epoprostenol; Escherichia coli; Female; Hemolysin Proteins; Hypertension, Pulmonary; In Vitro Techniques; L-Lactate Dehydrogenase; Lung; Male; Neutrophils; Perfusion; Potassium; Pulmonary Artery; Rabbits; Receptors, Prostaglandin; Receptors, Thromboxane; Respiratory Insufficiency; Sulfonamides; Thromboxane B2; Thromboxanes | 1991 |
Mediation of bradykinin-induced contraction in canine veins via thromboxane/prostaglandin endoperoxide receptor activation.
Topics: Animals; Bradykinin; Bridged Bicyclo Compounds, Heterocyclic; Dogs; Endothelium, Vascular; Fatty Acids, Unsaturated; Female; Hydrazines; Imidazoles; In Vitro Techniques; Muscle Contraction; Muscle, Smooth, Vascular; Prostaglandin Endoperoxides; Prostaglandin Endoperoxides, Synthetic; Prostaglandin H2; Prostaglandin-Endoperoxide Synthases; Prostaglandins H; Pyridines; Receptors, Prostaglandin; Sulfonamides; Thromboxane-A Synthase; Thromboxanes; Veins | 1990 |
Endothelin induces thromboxane release and contraction of isolated guinea-pig airways.
Topics: Animals; Anti-Arrhythmia Agents; Bronchi; Dose-Response Relationship, Drug; Endothelins; Epoprostenol; Guinea Pigs; Lung; Male; Muscle Contraction; Muscle, Smooth; Phenylacetates; Receptors, Prostaglandin; Receptors, Thromboxane; Sulfonamides; Thromboxane A2; Thromboxane B2; Thromboxanes; Trachea | 1990 |
Potent thromboxane-mediated in vitro bronchoconstrictor effect of endothelin in the guinea-pig.
Topics: Animals; Bronchi; Endothelins; Guinea Pigs; In Vitro Techniques; Male; Muscle Contraction; Peptides; Sulfonamides; Thromboxane A2; Thromboxanes; Trachea | 1990 |
Synergistic antiplatelet and antithrombotic effects of a prostacyclin analogue (iloprost) combined with a thromboxane antagonist (sulotroban) in guinea pigs and rats.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Cardiovascular Agents; Collagen; Drug Synergism; Epoprostenol; Fibrinolytic Agents; Guinea Pigs; Iloprost; Platelet Aggregation Inhibitors; Prostaglandin Endoperoxides, Synthetic; Rats; Sulfonamides; Thrombocytopenia; Thrombophlebitis; Thromboxanes | 1988 |
Role of endoperoxides in arachidonic acid-induced vasoconstriction in the isolated perfused kidney of the rat.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Anti-Arrhythmia Agents; Arachidonic Acids; Bridged Bicyclo Compounds, Heterocyclic; Fatty Acids, Unsaturated; Hydrazines; In Vitro Techniques; Kidney; Male; Prostaglandin Endoperoxides; Prostaglandin Endoperoxides, Synthetic; Prostaglandin H2; Prostaglandin-Endoperoxide Synthases; Prostaglandins G; Prostaglandins H; Rats; Rats, Inbred Strains; Receptors, Prostaglandin; Receptors, Thromboxane; Sulfonamides; Thromboxane A2; Thromboxane-A Synthase; Thromboxanes; Vasoconstriction | 1989 |
Characterization of N,N'-bis(3-picolyl)-4-methoxy-isophtalamide (picotamide) as a dual thromboxane synthase inhibitor/thromboxane A2 receptor antagonist in human platelets.
Topics: Arachidonic Acid; Arachidonic Acids; Blood Platelets; Cyclic AMP; Fibrinolytic Agents; Humans; Imidazoles; Phthalic Acids; Platelet Aggregation Inhibitors; Receptors, Prostaglandin; Receptors, Thromboxane; Sulfonamides; Thromboxane-A Synthase; Thromboxanes | 1989 |
Antiaggregatory effects of thromboxane receptor antagonists in vivo.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adenosine Triphosphate; Animals; Arachidonic Acid; Arachidonic Acids; Blood Platelets; Blood Pressure; Bridged Bicyclo Compounds, Heterocyclic; Collagen; Fatty Acids, Unsaturated; Fibrinolytic Agents; Hydrazines; Imidazoles; Kinetics; Male; Platelet Aggregation; Prostaglandin Endoperoxides, Synthetic; Rabbits; Receptors, Prostaglandin; Receptors, Thromboxane; Sulfonamides; Thromboxane-A Synthase; Thromboxanes | 1985 |
Influence of thromboxane receptor-antagonists on the interaction of platelets with solid-phase immobilized human collagen.
Topics: Blood Platelets; Collagen; Fatty Acids; Humans; Platelet Aggregation; Prostanoic Acids; Receptors, Prostaglandin; Receptors, Thromboxane; Sulfonamides; Thromboxanes | 1987 |
Thromboxane receptor blockade in an animal model of ARDS.
Topics: Animals; Anti-Arrhythmia Agents; Fibrinolytic Agents; Hemodynamics; Receptors, Prostaglandin; Receptors, Thromboxane; Respiratory Distress Syndrome; Sheep; Sulfonamides; Thromboxanes | 1988 |
Antiarrhythmic effects of the thromboxane antagonist BM 13.177.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Carbon Dioxide; Coronary Disease; Dogs; Hemodynamics; Oxygen; Sulfonamides; Thromboxanes | 1987 |
Effects of thromboxane A2 on lymphocyte proliferation.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Antibodies, Monoclonal; Cyclooxygenase Inhibitors; Dinoprostone; Humans; Imidazoles; Indomethacin; Lymphocyte Activation; Lymphocytes; Phytohemagglutinins; Platelet Aggregation; Prostaglandin Endoperoxides, Synthetic; Prostaglandins E; Receptors, Prostaglandin; Receptors, Thromboxane; Sulfonamides; Thromboxane A2; Thromboxane-A Synthase; Thromboxanes | 1985 |
Effects of the prostaglandin H2/thromboxane A2 antagonist BM 13.177 on human platelets.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Aspirin; Blood Platelets; Collagen; Humans; Prostaglandin Endoperoxides; Prostaglandin Endoperoxides, Synthetic; Prostaglandin H2; Prostaglandins H; Serotonin; Sulfonamides; Thrombin; Thromboxane A2; Thromboxanes | 1985 |
Relevance of eicosanoids for biochemical regulation of cardiac rhythm disturbances.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Arrhythmias, Cardiac; Epoprostenol; Fatty Acids, Unsaturated; Guinea Pigs; Male; Platelet Activating Factor; Prostaglandin Endoperoxides, Synthetic; Rats; Rats, Inbred Strains; Sulfonamides; Thromboxanes | 1987 |
Protective effects of the thromboxane receptor antagonists BM 13.177 and BM 13.505 against U 46619-induced sudden death in rats.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Anti-Arrhythmia Agents; Death, Sudden; Dose-Response Relationship, Drug; Electrocardiography; Male; Phenylacetates; Prostaglandin Endoperoxides, Synthetic; Rats; Rats, Inbred Strains; Respiration; Sulfonamides; Thromboxanes | 1988 |
Inhibitory effects of the selective thromboxane receptor antagonist BM 13.177 on platelet aggregation, vasoconstriction and sudden death.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Aorta; Arachidonic Acid; Arachidonic Acids; Blood Platelets; Dinoprost; Humans; Platelet Aggregation; Prostaglandin Endoperoxides, Synthetic; Prostaglandins F; Rats; Receptors, Cell Surface; Receptors, Prostaglandin; Receptors, Thromboxane; Serotonin; Sulfonamides; Thromboxanes; Vasoconstriction | 1984 |
The pharmacological profile of the thromboxane A2 antagonist BM 13.177. A new anti-platelet and anti-thrombotic drug.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Epoprostenol; Female; Fibrinolytic Agents; Guinea Pigs; Male; Muscle Contraction; Muscle, Smooth, Vascular; Platelet Aggregation; Prostaglandin Endoperoxides, Synthetic; Rabbits; Sulfonamides; Thrombosis; Thromboxane A2; Thromboxane B2; Thromboxanes | 1984 |
Investigation on a selective non-prostanoic thromboxane antagonist, BM 13.177, in human platelets.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Arachidonic Acid; Arachidonic Acids; Blood Platelets; Collagen; Dose-Response Relationship, Drug; Epinephrine; Humans; Hydrogen Peroxide; Imidazoles; Indomethacin; Platelet Aggregation; Prostaglandin Endoperoxides, Synthetic; Prostaglandins E; Serotonin; Sulfonamides; Thromboxane A2; Thromboxane B2; Thromboxanes | 1984 |
Endothelin-induced bronchoconstriction in perfused rat lungs is partly mediated by thromboxane.
Topics: Animals; Bronchoconstriction; Endothelins; Female; Peptide Fragments; Perfusion; Rats; Rats, Wistar; Receptors, Endothelin; Sulfonamides; Thromboxanes | 1995 |